Witnessing the stock’s movement on the chart, on N/A, Oncolytics Biotech, Inc (NASDAQ: ONCY) set off with pace as it heaved 1.43% to $1.42, before settling in for the price of $1.4 at the close. Taking a more long-term approach, ONCY posted a 52-week range of $0.33-$1.53.
It was noted that the giant of the Healthcare sector posted annual sales growth of 23.13% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 23.13%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 19.79%. This publicly-traded company’s shares outstanding now amounts to $100.36 million, simultaneously with a float of $98.09 million. The organization now has a market capitalization sitting at $143.77 million. At the time of writing, stock’s 50-day Moving Average stood at $1.1252, while the 200-day Moving Average is $0.8062.
Oncolytics Biotech, Inc (ONCY) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Oncolytics Biotech, Inc’s current insider ownership accounts for 2.27%, in contrast to 9.65% institutional ownership.
Oncolytics Biotech, Inc (ONCY) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
Oncolytics Biotech, Inc’s EPS increase for this current 12-month fiscal period is 19.79% and is forecasted to reach -0.25 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 9.40% through the next 5 years, which can be compared against the 23.13% growth it accomplished over the previous five years trading on the market.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Trading Performance Indicators
Let’s observe the current performance indicators for Oncolytics Biotech, Inc (ONCY). It’s Quick Ratio in the last reported quarter now stands at 2.88.
In the same vein, ONCY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.27, a figure that is expected to reach -0.06 in the next quarter, and analysts are predicting that it will be -0.25 at the market close of one year from today.
Technical Analysis of Oncolytics Biotech, Inc (ONCY)
Going through the that latest performance of [Oncolytics Biotech, Inc, ONCY]. Its last 5-days volume of 1.36 million indicated improvement to the volume of 1.02 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 67.74% While, its Average True Range was 68.80.
Raw Stochastic average of Oncolytics Biotech, Inc (ONCY) in the period of the previous 100 days is set at 92.40%, which indicates a major rise in contrast to 70.97% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0848 that was lower than 0.0889 volatility it exhibited in the past 100-days period.
